Pricing Log in Create free account

Canton Strategic Holdings, Inc. (CNTN) vs Jyong Biotech Ltd. (MENS)

Canton Strategic Holdings, Inc. and Jyong Biotech Ltd. are both Biotechnology companies. Canton Strategic Holdings, Inc. and Jyong Biotech Ltd. are of similar size ($149.0M and $147.0M). Across the 5 metrics below, Jyong Biotech Ltd. leads on 3 and Canton Strategic Holdings, Inc. on 2.

Valuation

Metric CNTN MENS Biotechnology median
P/E 9.01 — 8.50
P/S n/m — 9.71
P/B 0.81 n/m 2.13
Price to free cash flow n/m — 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield 11.10% — (33.15%)
Free cash flow yield (6.01%) — (25.50%)

Profitability

Metric CNTN MENS Biotechnology median
Gross margin — — 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% — 0.00%
Free cash flow margin 0.00% — 0.00%
Return on equity (43.10%) — (56.36%)
Return on assets (34.60%) — (48.04%)
Return on invested capital (8.11%) 0.00% 0.00%

Growth

Metric CNTN MENS Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 88.10% (42.18%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CNTN MENS Biotechnology median
Debt to equity 0.00 (0.74) 0.00
Current ratio 15.70 0.45 4.72
Net debt to EBITDA 0.85 (6.89) 0.96

Dividend

Metric CNTN MENS Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CNTN MENS Biotechnology median
Market cap 149.01m 146.98m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack